Sign in

jsc-bacterio.bsky.social

@jsc-bacterio.bsky.social
35 followers 28 following 6 posts
PostsRepliesMedia
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 27/08/2026
The first @esgrev_escmid 2026–2027 webinar is coming up on October 8: ESGREV & ICHS: Infection Control Debates: Lessons Learned From the COVID-19 Pandemic Speakers: Dr. Steve Pergam and Dr. Amy Spallone Chairs: Dr. Siran Keske and Dr. Michelle Yong us06web.zoom.us/webinar/regi...
us06web.zoom.us
Welcome! You are invited to join a webinar: ESGREV & ICHS: Infection Control Debates: Lessons Learned From the COVID-19 Pandemic. After registering, you will receive a confirmation email about joining...
Speakers: Pros: Masking, Airborne, Retesting, and CT Values Steve Pergam Cons: No Masking, No Airborne, No Retesting and Definitely No CT Values Amy Spallone Chairs: Siran Keske Michelle Yong
011
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 26/08/2026
Vaccination and Safe Living Strategies for Solid Organ Transplant Candidates and Recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice www.sciencedirect.com/science/arti...
sciencedirect.com
Vaccination and Safe Living Strategies for Solid Organ Transplant Candidates and Recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
These updated guidelines of the AST IDCOP review safe living practices including routine vaccinations, travel vaccinations including general travel ad…
011
jsc-bacterio.bsky.social @jsc-bacterio.bsky.social · 14/04/2026
@esgrev-escmid.bsky.social Excited to take on this new challenge with this fantastic team and to contribute to the growth of ESGREV. See you all in Munich at #ESCMIDGlobal2026
032
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 03/02/2026
The @SAMICEI-GEIDS group (Study Group on Infections in Primary and Secondary Immunodeficiencies) invites you to the III GEIDS–SAMICEI Training Conference, which will take place on March 19, 2026, in Seville (@ibis_sevilla).
111
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 22/01/2026
ESGICH Board announce the availability of 5 grants to support attendance at the ESGICH Course “Infections in Immunocompromised Patients” (Bologna, 6–7 March 2026). Each scholarship consists of a €500 grant to contribute to participation-related costs (travel not included). mailchi.mp/22ce8403d3b8...
mailchi.mp
Grants for ID Trainees: ESGICH Course in Bologna (6–7 March 2026)
022
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 03/12/2025
Now available the new recommendations from the European Conference on Infections in Leukaemia for empirical and targeted antimicrobial therapy in patients with febrile neutropenia and hematological malignancy or after hematopoietic cell transplantation: thelancet.com/journals/lan...
thelancet.com
Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Con...
Febrile neutropenia can lead to life-threatening infections in patients with haematological malignancies or after hematopoietic cell transplantation. Infection management is challenged by rising antib...
022
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 16/10/2025
CMV Global "Update en Citomegalovirus: Diagnóstico y tratamiento" (Sesión 1) 📅28th October, 2025 📍Online 📚📝Programme/registration👇 update-citomegalovirus-cmvglobal.com
update-citomegalovirus-cmvglobal.com
update-citomegalovirus-cmvglobal.com – Update en Citomegalovirus: diagnóstico y tratamiento
022
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 06/10/2025
New systematic review on the epidemiology of resistant bacterial infections in patients with hematological malignancies or HSCT recipients by the European Conference on Infections in Leukemia (ECIL) www.journalofinfection.com/article/S016...
022
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 03/10/2025
📣 GESITRA-IC Meeting is coming! 📍 Madrid | 5–6 March 2026 🗓️ Save the date!
022
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 11/08/2025
The presentations from the 4th GESITRA-IC Scientific Meeting, held in Barcelona last June, are now available on the group's website. seimc.org/grupos-de-es...
011
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 01/08/2025
Hurry up, registration is free and capacity is limited!!!
011
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 27/07/2025
📝 Desde GESITRA-IC os invitamos a completar esta breve encuesta para actualizar los perfiles profesionales del grupo y orientar vuestra participación en futuras colaboraciones, proyectos y actividades. 📅 Hasta el 14 de agosto 👉 forms.gle/29cVVZnsT9A7uq… ¡Gracias por participar!
forms.gle
022
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 10/07/2025
This symposium will provide state-of-the-art discussion on hot topics in the field of transplant infectious diseases. Chaired by Shahid Husain and Deepali Kumar events.myconferencesuite.com/Transplant_I...
034
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 09/07/2025
Great review and meta-analysis identifying areas of research on antimicrobial stewardship in SOTr that require the highest priority @ibis-investigacion.bsky.social @isciiisalud.bsky.social
043
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 09/07/2025
Effectiveness and safety of strategies to optimise antimicrobial use in solid organ transplant recipients. Systematic review and meta-analyses - eClinicalMedicine www.thelancet.com/journals/ecl...
thelancet.com
Effectiveness and safety of strategies to optimise antimicrobial use in solid organ transplant recipients. Systematic review and meta-analyses
Strategies to optimise antimicrobial use are safe, with no negative impact on mortality or transplant-related complications, and appear to improve some clinical outcomes in SOTr, particularly when usi...
123
Reposted by @jsc-bacterio.bsky.social
Jon Salmanton-García @salmantongarcia.bsky.social · 04/07/2025
🚨 #Antifungal #prophylaxis in #SOT patients is evolving—but not uniformly. A new survey by @efisg-escmid.bsky.social @ESGICH @SITA @seimc.bsky.social @gesitraic-seimc.bsky.social sheds light on how prophylaxis is actually being used in transplant centers. 👇👇 link.springer.com/article/10.1...
link.springer.com
Current trends on antifungal prophylaxis in solid organ transplantation: a study from ESCMID-EFISG, ESCMID-ESGICH, SITA, and SEIMC-GESITRA-IC - Infection
Introduction Invasive fungal diseases (IFD) present serious risks to solid organ transplant recipients, particularly in the first 180 days post-transplant. Existing European and US guidelines offer li...
144
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 09/07/2025
Pneumocystis jirovecii pneumonia in immunocompromised patients. Observational Analysis of a Large Cohort of Pneumocystis jirovecii Pneumonia url: academic.oup.com/ofid/article...
academic.oup.com
An Observational Analysis of a Large Cohort of Pneumocystis jirovecii Pneumonia
Pneumocystis jirovecii pneumonia is increasingly diagnosed in non-HIV immunocompromised patients. In this multicenter cohort, we observed rising diagnoses,
053
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 09/07/2025
No differences in results when evaluating subgroups with a particularly high risk of recurrent infection, such as immunocompromised individuals. jamanetwork.com/journals/jam...
jamanetwork.com
Oral Vancomycin for Prevention of Recurrent Clostridioides difficile Infection
This randomized clinical trial examines whether prophylactic oral vancomycin vs placebo reduces recurrent Clostridioides difficile infection in adults receiving antibiotics for another indication.
022
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 09/07/2025
People who are older or immunocompromised are at higher risk of severe disease and death. Since there are no therapies or human vaccines, prevention relies on personal protective measures, WNV surveillance, and mosquito control interventions. jamanetwork.com/journals/jam...
jamanetwork.com
West Nile Virus: A Review
This narrative review summarizes the pathophysiology, epidemiology, diagnosis, treatment, and prevention of West Nile virus infection.
033
Reposted by @jsc-bacterio.bsky.social
gesitraic-seimc.bsky.social @gesitraic-seimc.bsky.social · 09/07/2025
Organ transplants between people with HIV, backed by solid international studies, have been given the green light in Spain. Upcoming protocols will mark the beginning of this practice, which promotes equality in healthcare. @gesida-seimc.bsky.social @sanidad.gob.es www.sanidad.gob.es
sanidad.gob.es
Ministerio de Sanidad
Sitio Web del Ministerio de Sanidad
053
jsc-bacterio.bsky.social @jsc-bacterio.bsky.social · 26/05/2025
cursos.cientifis.com/c-terapiasan...
cursos.cientifis.com
Webinar CIBERISCIII
El Centro de Investigación Biomédica en Red, CIBER, tiene como objetivo impulsar la investigación de excelencia en Biomedicina y Ciencias de la Salud que se realiza en el Sistema Nacional de Salud y e...
000
Reposted by @jsc-bacterio.bsky.social
CSIC @csic.es · 02/05/2025
🔬El #CSIC es el mayor organismo científico de España, con 124 institutos. Sus equipos realizan investigación básica para ampliar las fronteras del conocimiento 🧵 En este hilo te contamos las noticias destacadas de esta #SemanaCSIC ➡️ bit.ly/4908GgY
1189
Reposted by @jsc-bacterio.bsky.social
CSIC @csic.es · 29/04/2025
🦠Un estudio liderado por el @ibis-investigacion.bsky.social identifica una molécula antiviral de amplio espectro 🔬El trabajo muestra la eficacia y seguridad de esta molécula para combatir las infecciones causadas virus 👉 tiny.cc/zm3i001
04014
Reposted by @jsc-bacterio.bsky.social
Gladstone Institutes @gladstoneinst.bsky.social · 24/04/2025
🚨 NEW PUBLICATION 🚨 "Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus MPro inhibitors with potent in vivo efficacy" @theottlab.bsky.social @ucsfmedicine.bsky.social @qbi-ucsf.bsky.social
science.org
Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus MPro inhibitors with potent in vivo efficacy
This study describes a class of potent, bioavailable SARS-CoV-2 MPro inhibitors having an unusual mechanism of inhibition.
022
jsc-bacterio.bsky.social @jsc-bacterio.bsky.social · 25/04/2025
link.springer.com/article/10.1...
link.springer.com
Neural Responses to Hypoxic Injury in a Vascularized Cerebral Organoid Model - Neuroscience Bulletin
Hypoxic injury (HI) in the prenatal period often causes neonatal neurological disabilities. Due to the difficulty in obtaining clinical samples, the molecular and cellular mechanisms remain unclear. H...
000
jsc-bacterio.bsky.social @jsc-bacterio.bsky.social · 25/04/2025
x.com/ncats_nih_go...
x.com
NCATS on X: "New treatments take far too long to develop — they require an average of 10–15 years & fail 95% of the time. NCATS was formed to transform the #TranslationalScience process, shortening the journey from scientific discovery to better health. Learn more about our vision of more https://t.co/IPtCtkXCUH" / X
New treatments take far too long to develop — they require an average of 10–15 years & fail 95% of the time. NCATS was formed to transform the #TranslationalScience process, shortening the journey from scientific discovery to better health. Learn more about our vision of more https://t.co/IPtCtkXCUH
000
jsc-bacterio.bsky.social @jsc-bacterio.bsky.social · 24/04/2025
Organoids in Dynamic Culture: Microfluidics and 3D Printing Technologies | ACS Biomaterials Science & Engineering pubs.acs.org/doi/10.1021/...
pubs.acs.org
Organoids in Dynamic Culture: Microfluidics and 3D Printing Technologies
With the rapid advancement of biomaterials and tissue engineering technologies, organoid research and its applications have made significant strides. Organoids are increasingly utilized in pharmacolog...
000